<DOC>
	<DOC>NCT01110525</DOC>
	<brief_summary>The primary purpose of this study is to determine whether the treatment with AZD1981 will affect the metabolism of hormones included in oral contraceptives.</brief_summary>
	<brief_title>A Drug-drug Interaction Study to Investigate the Effects of AZD1981 on the Metabolism and Pharmacodynamics of Oral Contraceptives</brief_title>
	<detailed_description />
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Females of childbearing potential Use of Neovletta or Neovletta 28 minimum 3 months prior to enrolment. Willing to use a highly effective method of birth control, ie, double barrier method contraception. Pregnancy and/or lactation or delivery/abortion within 6 months prior to randomisation. Any clinically significant disease or disorder. Any clinically relevant abnormal findings in physical examination.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Drug-drug interaction</keyword>
	<keyword>Oral contraceptives</keyword>
	<keyword>AZD 1981</keyword>
</DOC>